Robert W. Simms

21.1k total citations · 2 hit papers
87 papers, 5.5k citations indexed

About

Robert W. Simms is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Robert W. Simms has authored 87 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Pathology and Forensic Medicine, 23 papers in Molecular Biology and 21 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Robert W. Simms's work include Systemic Sclerosis and Related Diseases (42 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (14 papers) and Dermatologic Treatments and Research (13 papers). Robert W. Simms is often cited by papers focused on Systemic Sclerosis and Related Diseases (42 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (14 papers) and Dermatologic Treatments and Research (13 papers). Robert W. Simms collaborates with scholars based in United States, Netherlands and Brazil. Robert W. Simms's co-authors include Robert Lafyatis, Don L. Goldenberg, Maria Trojanowska, John Varga, David T. Felson, Alan S. Cohen, Christopher P. Denton, Janet Pope, Yannick Allanore and Oliver Distler and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Annals of Internal Medicine.

In The Last Decade

Robert W. Simms

87 papers receiving 5.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Systemic sclerosis

2015 575 citations Yannick Allanore, Robert W. Simms et al. Nature Reviews Disease Primers profile →
Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients

2015 265 citations Lisa Rice, Jessica Ziemek et al. profile →

Peers

Countries citing papers authored by Robert W. Simms

Since Specialization

Citations

This map shows the geographic impact of Robert W. Simms's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert W. Simms with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert W. Simms more than expected).

Fields of papers citing papers by Robert W. Simms

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert W. Simms. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert W. Simms. The network helps show where Robert W. Simms may publish in the future.

Co-authorship network of co-authors of Robert W. Simms

This figure shows the co-authorship network connecting the top 25 collaborators of Robert W. Simms. A scholar is included among the top collaborators of Robert W. Simms based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert W. Simms. Robert W. Simms is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Autologous Nonmyeloablative Hematopoietic Stem Cell Transplantation for Diffuse Cutaneous Systemic Sclerosis: Identifying Disease Risk Factors for Toxicity and Long‐Term Outcomes in a Prospective, Single‐Arm Trial 2024 ·Arthritis & Rheumatology ·George E. Georges, Dinesh Khanna, Mark H. Wener, Matthew Mei, Maureen D. Mayes, Robert W. Simms, Vaishali Sanchorawala, Chitra Hosing, Suzanne Kafaja, Attaphol Pawarode, Leona Holmberg, Jason Kolfenbach, Daniel E. Furst, Keith M. Sullivan, Suiyuan Huang, Ted Gooley, Richard A. Nash	1
2	Adipose‐Derived Regenerative Cell Transplantation for the Treatment of Hand Dysfunction in Systemic Sclerosis: A Randomized Clinical Trial 2022 ·Arthritis & Rheumatology ·Dinesh Khanna, Paul H. Caldron, Richard W. Martin, Suzanne Kafaja, Robert Spiera, (unknown), Ankoor R. Shah, Vivien Hsu, John Ervin, Robert W. Simms, Robyn T. Domsic, Virginia Steen, Laura K. Hummers, Chris T. Derk, Maureen D. Mayes, Soumya Chatterjee, John Varga, Steven Kesten, John K. Fraser, Daniel E. Furst	20
3	Safety and Efficacy of Lenabasum in a Phase II, Randomized, Placebo‐Controlled Trial in Adults With Systemic Sclerosis 2020 ·Arthritis & Rheumatology ·Robert Spiera, Laura K. Hummers, Leland W.K. Chung, Tracy Frech, Robyn T. Domsic, Vivien Hsu, Daniel E. Furst, Jessica Gordon, Maureen D. Mayes, Robert W. Simms, Robert Lafyatis, Viktor Martyanov, Tammara Wood, Michael L. Whitfield, S. Constantine, Elizabeth Lee, Nancy Dgetluck, Barbara White	72
4	Microbiome dysbiosis is associated with disease duration and increased inflammatory gene expression in systemic sclerosis skin 2019 ·Arthritis Research & Therapy ·Michael E. Johnson, Jennifer M. Franks, Guoshuai Cai, Bhaven K. Mehta, Tammara Wood, (unknown), Patricia A. Pioli, Robert W. Simms, Nicole M. Orzechowski, Sarah T. Arron, Michael L. Whitfield	27
5	Serum biomarker for diagnostic evaluation of pulmonary arterial hypertension in systemic sclerosis 2018 ·Arthritis Research & Therapy ·Lisa Rice, Julio Mantero, (unknown), Rod R. Warburton, Kari E. Roberts, Nicholas S. Hill, Robert W. Simms, Robyn T. Domsic, Harrison W. Farber, (unknown)	17
6	Inhibition of β-Catenin Signaling in the Skin Rescues Cutaneous Adipogenesis in Systemic Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Trial of C-82 2017 ·Journal of Investigative Dermatology ·Robert Lafyatis, Julio Mantero, Jessica Gordon, (unknown), Mary Carns, Howard C. Dittrich, Robert Spiera, Robert W. Simms, John Varga	38
7	miR-155 in the progression of lung fibrosis in systemic sclerosis 2016 ·Arthritis Research & Therapy ·Romy Christmann, (unknown), Percival D. Sampaio‐Barros, (unknown), Carlos Roberto Ribeiro de Carvalho, Ronaldo Adib Kairalla, Carol Feghali‐Bostwick, Jessica Ziemek, (unknown), Salma Goummih, Jiangning Tan, Diana Álvarez, Daniel J. Kass, Mauricio Rojas, (unknown), Edwin Roger Parra, Giuseppina Stifano, Vera Luíza Capelozzi, Robert W. Simms, Robert Lafyatis	85
8	A Proteome-Derived Longitudinal Pharmacodynamic Biomarker for Diffuse Systemic Sclerosis Skin 2016 ·Journal of Investigative Dermatology ·Lisa Rice, Julio Mantero, Giuseppina Stifano, Jessica Ziemek, Robert W. Simms, Jessica Gordon, Robyn T. Domsic, Robert Lafyatis	27
9	Systemic sclerosis breakdown → 2015 ·Nature Reviews Disease Primers ·Yannick Allanore, Robert W. Simms, Oliver Distler, Maria Trojanowska, Janet Pope, Christopher P. Denton, John Varga	575
10	Changes in forced vital capacity over time in systemic sclerosis: application of group-based trajectory modelling 2015 ·Lara D. Veeken ·Ada Man, (unknown), Laura T. Ferguson, Michael H. Ieong, Yuqing Zhang, Robert W. Simms	59
11	Ultrasound Assessment of Subcutaneous Compressibility 2013 ·JCR Journal of Clinical Rheumatology ·Eugene Y. Kissin, Amit Garg, Peter C. Grayson, Maureen Dubreuil, Diana Vradii, Michael York, Robert W. Simms	16
12	B cell depletion with rituximab in patients with diffuse cutaneous systemic sclerosis 2009 ·Arthritis & Rheumatism ·Robert Lafyatis, Eugene Y. Kissin, Michael York, Giuseppina Farina, (unknown), Marvin J. Fritzler, Peter A. Merkel, Robert W. Simms	214
13	A multicenter, randomized, double‐blind, placebo‐controlled trial of oral type I collagen treatment in patients with diffuse cutaneous systemic sclerosis: I. Oral type I collagen does not improve skin in all patients, but may improve skin in late‐phase disease 2008 ·Arthritis & Rheumatism ·Arnold E. Postlethwaite, Weng Kee Wong, Philip J. Clements, Soumya Chatterjee, Barri J. Fessler, Andrew H. Kang, Joseph H. Korn, Maureen D. Mayes, Peter A. Merkel, Jerry A. Molitor, Larry W. Moreland, Naomi F. Rothfield, Robert W. Simms, Edwin A. Smith, Robert Spiera, Virginia Steen, Kenneth J. Warrington, Barbara White, Frederick M. Wigley, Daniel E. Furst	82
14	Field guide to soft tissue pain : diagnosis and management 2001 ·Lippincott Williams & Wilkins eBooks ·Robert W. Simms	1
15	Results of a phase-I/II randomized, masked, placebo-controlled trial of recombinant human interleukin-11 (rhIL-11) in the treatment of subjects with active rheumatoid arthritis 2001 ·Arthritis Research & Therapy ·Larry W. Moreland, (unknown), Kevin R. King, (unknown), Michael Weisman, Thomas Greco, Rose Fife, Joseph H. Korn, Robert W. Simms, John Tesser, Jan Hillson, Jacques R. Caldwell, Thomas J. Schnitzer, D. Lyons, Ullrich Schwertschlag	41
16	Recombinant Human Relaxin in the Treatment of Scleroderma 2000 ·Annals of Internal Medicine ·James R. Seibold, Joseph H. Korn, Robert W. Simms, Phillip J. Clements, Larry W. Moreland, Maureen D. Mayes, Daniel E. Fürst, Naomi F. Rothfield, Virginia Steen, Michael Weisman, David H. Collier, Fredrick M. Wigley, Peter A. Merkel, Mary Ellen Csuka, Vivien Hsu, (unknown), Mark Erikson, John H. Hannigan, W. Scott Harkonen, Martin E. Sanders	44
17	Fibromyalgia syndrome: Current concepts in pathophysiology, clinical features, and management 1996 ·Arthritis & Rheumatism ·Robert W. Simms	34
18	Muscle Studies in Fibromyalgia Syndrome 1994 ·Journal of Musculoskeletal Pain ·Robert W. Simms	6
19	Lack of association between fibromyalgia syndrome and abnormalities in muscle energy metabolism 1994 ·Arthritis & Rheumatism ·Robert W. Simms, Serge H. Roy, Mirko I. Hrovat, Jennifer J. Anderson, Gary S. Skrinar, (unknown), Cristiano A. F. Zerbini, Carlo De Luca, Ferenc A. Jólesz	101
20	Fibromyalgia syndrome in patients infected with human immunodeficiency virus 1992 ·The American Journal of Medicine ·Robert W. Simms, Cristiano A. F. Zerbini, (unknown), John Anthony, David T. Felson, Donald E. Craven	63

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact